By Carolin Arndt Foppa
Led by Sven Panke’s Bioprocess Lab at ETH Zurich, a consortium of partners from industry and academia from across Europe recently kicked off “NEWmRNA”, a synthetic biology project funded by a 3 Mio€-EIC Pathfinder grant. Given the diverse role and growing importance of mRNA-applications in many economic sectors, the 4-year project aims to pave the way for new forms of mRNA and for mass producing them.